Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT06929169
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 and ≤70 years
* Diagnosed with end-stage renal disease
* Undergoing online hemodiafiltration for at least 3 months
* Able to provide written informed consent
Exclusion Criteria:
* Current immunosuppressive therapy
* Contraindication to cardiac MRI
* Known hypersensitivity or intolerance to SGLT2 inhibitors
* Participation in another interventional clinical trial
* History of diabetic ketoacidosis
* Active substance abuse
* Diagnosis of type 1 diabetes mellitus
* History of kidney transplantation
* Acute coronary event within 30 days before enrollment
* Current or recent treatment with an SGLT2 inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT06929169
Study Brief:
Protocol Section:
NCT06929169